Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study

被引:16
作者
Hag-Yahia, Nasreen [1 ]
Gemer, Ofer [2 ]
Eitan, Ram [3 ]
Raban, Oded [3 ]
Vaknin, Zvi [4 ]
Levy, Tally [5 ]
Leytes, Sofia [5 ]
Lavie, Ofer [6 ]
Ben-Arie, Alon [7 ]
Amit, Amnon [8 ]
Namazov, Ahmed [2 ]
Volodarsky, Michael [2 ]
Ben-Shachar, Inbar [9 ]
Atlas, Ilan [10 ]
Bruchim, Ilan [11 ]
Kadan, Yfat [1 ]
Helpman, Limor [1 ,12 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel
[2] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Univ Med Ctr, Dept Obstet & Gynecol, Ashqelon, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Dept Obstet & Gynecol, Rabin Med Ctr, Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Dept Obstet & Gynecol, Assaf Haroffe Med Ctr, Zerifin, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Dept Obstet & Gynecol, Wolfson Med Ctr, Holon, Israel
[6] Technion, Rappaport Fac Med, Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
[7] Hebrew Univ Jerusalem, Dept Obstet & Gynecol, Kaplan Med Ctr, Rehovot, Israel
[8] Technion, Rappaport Fac Med, Rambam Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
[9] Bar Ilan Univ, Dept Obstet & Gynecol, Ziv Med Ctr, Safed, Israel
[10] Bar Ilan Univ, Poriya Med Ctr, Dept Obstet & Gynecol, Tiberias, Israel
[11] Technion, Rappaport Fac Med, Hillel Yaffe Med Ctr, Dept Obstet & Gynecol, Hadera, Israel
[12] McMaster Univ, Div Gynecol Oncol, Juravinski Canc Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada
关键词
age; endometrial cancer; older adults; older women; uterine cancer; ELDERLY-WOMEN; OPEN-LABEL; SURGERY; MANAGEMENT; CARCINOMA; SURVIVAL; IMPACT; RADIOTHERAPY; MORBIDITY; CHEMOTHERAPY;
D O I
10.1111/aogs.14015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction Advanced age is considered an adverse factor in endometrial cancers but may be a surrogate for other conditions that impact outcomes. The study objective was to assess the association of age with endometrial cancer features, treatment and prognosis. Material and methods In this multicenter cohort study, consecutive women with endometrial cancer treated at 10 Israeli institutions between 2000 and 2014 were accrued in an assimilated database. Postmenopausal women were stratified into age groups with a cut-off of 80. Clinical, pathological and treatment data were compared using t test or Mann-Whitney test for continuous variables, and Chi-square Test or Fisher's Exact test for categorical variables. Main outcome measures included disease recurrence and disease-specific and overall survival; these were plotted using the Kaplan-Meier method and compared using the log-rank test. The association between age and recurrence and survival, adjusted for other clinical and pathological factors, was assessed using multivariable Cox regression modeling. Results A total of 1764 postmenopausal women with endometrial cancer were identified. Adverse pathological features were more prevalent in older women, including high-risk histologies (35% vs 27%, P = .025), deep myoinvasion (44% vs 29%, P = .001) and lymphovascular involvement (22% vs 15%, P = .024). Surgical staging was performed less frequently among older women (33% vs 56%; P < .001). Chemotherapy was less often prescribed, even for non-endometrioid histologies (72% vs 45%; P < .001). On multivariable analysis, age remained a significant predictor for recurrence (HR = 1.75, P = .007), death of disease (HR = 1.89, P = .003) and death (HR = 2.4, P < .001). Conclusions Older age in women with endometrial cancer is associated with more adverse disease features, limited surgery and adjuvant treatment, and worse outcomes. On multivariable analysis, age remains an independent prognosticator in this population.
引用
收藏
页码:444 / 452
页数:9
相关论文
共 34 条
  • [1] The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002
    Ahmed, Amina
    Zamba, Gideon
    DeGeest, Koen
    Lynch, Charles F.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 111 (01) : 35 - 40
  • [2] Is endometrial carcinoma intrinsically more aggressive in elderly patients?
    Alektiar, KM
    Venkatraman, E
    Abu-Rustum, N
    Barakat, RR
    [J]. CANCER, 2003, 98 (11) : 2368 - 2377
  • [3] [Anonymous], 2013, STAT AG HLTH AM 2013
  • [4] Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
    Bernardini, Marcus Q.
    Gien, Lilian T.
    Lau, Susie
    Altman, Alon D.
    Gilks, Blake
    Ferguson, Sarah E.
    Koebel, Martin
    Samouelian, Vanessa
    Wesa, Mina
    Cameron, Anna
    Nelson, Gregg
    Han, Guangming
    Clarke, Blaise
    Ho, T. C.
    Panzarella, Tony
    Atenafu, Eshetu G.
    McAlpine, Jessica N.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 141 (01) : 148 - 154
  • [5] The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer Survival Outcomes and Patterns of Care
    Boothe, Dustin
    Williams, Ned
    Odei, Bismarck
    Poppe, Matthew M.
    Werner, Theresa L.
    Suneja, Gita
    Gaffney, David K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 912 - 922
  • [6] Impact of age on surgical staging and approaches (laparotomy, laparoscopy and robotic surgery) in endometrial cancer management
    Bourgin, C.
    Lambaudie, E.
    Houvenaeghel, G.
    Foucher, F.
    Leveque, J.
    Lavoue, V.
    [J]. EJSO, 2017, 43 (04): : 703 - 709
  • [7] Endometrial cancer in elderly women: Which disease, which surgical management? A systematic review of the literature
    Bourgin, C.
    Saidani, M.
    Poupon, C.
    Cauchois, A.
    Foucher, F.
    Leveque, J.
    Lavoue, V.
    [J]. EJSO, 2016, 42 (02): : 166 - 175
  • [8] Adjuvant Treatment and Clinical Trials in Elderly Patients With Endometrial Cancer A Time for Change?
    Clark, Leslie H.
    Jackson, Amanda L.
    Gehrig, Paola A.
    Bae-Jump, Victoria
    Linda Van Le
    Ko, Emily M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (02) : 282 - 289
  • [9] Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
    Creutzberg, CL
    van Putten, WLJ
    Koper, PCM
    Lybeert, MLM
    Jobsen, JJ
    Wárlám-Rodenhuis, CC
    De Winter, KAJ
    Lutgens, LCHW
    van den Bergh, ACM
    van de Steen-Banasik, E
    Beerman, H
    van Lent, M
    [J]. LANCET, 2000, 355 (9213) : 1404 - 1411
  • [10] Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Kitchener, Henry C.
    Nijman, Hans W.
    Kruitwagen, Roy F.
    Nout, Remi A.
    Verhoeven-Adema, Karen W.
    Smit, Vincent T.
    Putter, Hein
    Creutzberg, Carien L.
    [J]. LANCET ONCOLOGY, 2016, 17 (08) : 1114 - 1126